LIAISON Calprotectin
Device
DiaSorin Inc.
Total Payments
$575,092
Transactions
18
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $32,850 | 3 | 0 |
| 2018 | $538,167 | 13 | 0 |
| 2017 | $4,075 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $575,092 | 18 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CALFE Sample Collection Study C-001 | DiaSorin Inc. | $538,167 | 0 |
| LIAISON Calprotectin Project | DiaSorin Inc. | $32,850 | 0 |
| LIAISON Calprotectin | DiaSorin Inc. | $4,075 | 0 |
Top Doctors Receiving Payments for LIAISON Calprotectin
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Asheville, NC | $575,092 | 18 |
Ad
Manufacturing Companies
- DiaSorin Inc. $575,092
Product Information
- Type Device
- Total Payments $575,092
- Total Doctors 0
- Transactions 18
About LIAISON Calprotectin
LIAISON Calprotectin is a device associated with $575,092 in payments to 0 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Inc..
Payment data is available from 2017 to 2019. In 2019, $32,850 was paid across 3 transactions to 0 doctors.
The most common payment nature for LIAISON Calprotectin is "Unspecified" ($575,092, 100.0% of total).
LIAISON Calprotectin is associated with 3 research studies, including "CALFE Sample Collection Study C-001" ($538,167).